ONTOFORCE

ONTOFORCE, founded in 2011 and headquartered in Belgium, is carving a niche in the intersection of Analytics, Biotechnology, Data Analytics, IT, Information Technology, Life Sciences, and Pharmaceutical sectors. The company’s ethos, "Through our data and technology solutions, we transform data into actionable insights, and streamline drug development," reflects its pioneering role in facilitating drug development processes.

At the heart of ONTOFORCE is DISQOVER, a robust knowledge discovery platform utilizing knowledge graph and semantic technologies. This intuitive tool integrates siloed data, enabling users to search across public and private sources with ease. It is particularly beneficial for life sciences companies, granting swift, comprehensive access to critical insights for roles ranging from researchers to business users. Esteemed clients like AstraZeneca, Amgen, and Princess Máxima Center for Pediatric Oncology attest to its efficacy.

The company last secured a €4.30M Series A investment on 25 January 2018, backed by investors including Limburgse Reconversie Maatschappij, PMV, Korys, Luc Vauterin, and Opdorp Finance BVBA. ONTOFORCE continues to be a persuasive proposition for further investment, with its strong industry foothold and transformative technology.